Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways

J Am Coll Cardiol. 2022 May 31;79(21):2144-2152. doi: 10.1016/j.jacc.2022.03.346. Epub 2022 Mar 29.


A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.

Keywords: COVID-19; fulminant myocarditis; ventricular arrhythmias.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Arrhythmias, Cardiac / complications
  • COVID-19* / complications
  • Critical Pathways
  • Extracorporeal Membrane Oxygenation*
  • Female
  • Humans
  • Middle Aged
  • Myocarditis* / diagnosis
  • Myocarditis* / etiology
  • Myocarditis* / therapy
  • SARS-CoV-2